Skip to main content
Craig Gerard, MD, Internal Medicine, Boston, MA

CraigJGerardMD

Internal Medicine Boston, MA

Pulmonology

Professor

Dr. Gerard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gerard's full profile

Already have an account?

  • Office

    300 Longwood Ave
    Boston, MA 02115
    Phone+1 617-355-1900
    Fax+1 617-730-0084

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1988
  • Harvard Medical School
    Harvard Medical SchoolFellowship, 1985 - 1987
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1985 - 1986
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1985, MD
  • Research Institute of Scripps Clinic
    Research Institute of Scripps ClinicPost-Doctoral Fellowship, 1981 - 1981
  • University of California
    University of CaliforniaM.S., Ph.D, Chemistry, 1981
  • University of California
    University of CaliforniaFellowship, 1977 - 1980
  • University of Connecticut
    University of ConnecticutB.A, 1976

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1987 - 2019

Awards, Honors, & Recognition

  • RJR Nabisco Faculty Scholar Harvard Medical School (1989-1992), 1992
  • American Society for Clinical Investigation 1992
  • Elected Member The American Society for Clinical Investigation, 1992
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Molecular aspects of the serum chemotactic factors.  
    GERARD C, Chenoweth DE, Hugli TE, J Reticuloendothel Soc 1979; 26(Suppl): 711-8
  • C5a: a mediator of chemotaxis and cellular release reactions.  
    GERARD C, Hugli TE, Kroc Found Ser 1981; 14: 147-160
  • Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli.  
    Franke AE, Andrews GC, Stimler-Gerard NP, GERARD C, Showell HJ, Methods Enzymol 1988; 162: 653-668
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • NEP Knockout Mouse. 
    1st International Symposium of Cardiovascular Endocrinology and Metabolism, Kyoto, Japan
  • Early Disease-How does it Start? 
    Cystic Fibrosis Foundation, Williamsburg Conference, Williamsburg, VA
  • HIV and Chemokines. 
    NIH, Washington, DC
  • Join now to see all

Other

  • AIDS vaccine development. 
    Agosto M, Allan J, Benson C, Berger EA, Blumenthal R, Burton D, Clements J, Coffin J, Connor R, Cullen B, Desrosiers R, Dimitrov D, Doms R, Emerman M, Feinberg M, Fult..., Science 1998; 280: 803
  • For whom the bell tolls. 
    GERARD C, Nature 1998; 395: 217-219

Press Mentions

  • Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice
    Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone MiceJuly 30th, 2020